{
  "total": 1052,
  "confounded": [
    {
      "drug": "digitoxin",
      "disease": "type 2 diabetes",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "Na+/K+-ATPase inhibition reduces GLUT4 translocation, worsening glucose",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 0,
      "pub_count": 1
    },
    {
      "drug": "simvastatin",
      "disease": "type 2 diabetes",
      "type": "inverse_indication",
      "confidence": 0.9,
      "reason": "Statins INCREASE T2D risk (HR 1.12-1.44) but prescribed for CV protection",
      "evidence": "Drug is known to CAUSE or WORSEN this condition",
      "trial_count": 33,
      "pub_count": 345
    },
    {
      "drug": "digoxin",
      "disease": "type 2 diabetes",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "Na+/K+-ATPase inhibition reduces GLUT4 translocation, worsening glucose",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 8,
      "pub_count": 45
    },
    {
      "drug": "felodipine",
      "disease": "type 2 diabetes mellitus",
      "type": "cardiac_metabolic",
      "confidence": 0.5,
      "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
      "evidence": "HF and T2D frequently co-occur, creating false association",
      "trial_count": 0,
      "pub_count": 2
    },
    {
      "drug": "hydrochlorothiazide",
      "disease": "type 2 diabetes mellitus",
      "type": "inverse_indication",
      "confidence": 0.9,
      "reason": "Thiazides cause hyperglycemia but prescribed for hypertension",
      "evidence": "Drug is known to CAUSE or WORSEN this condition",
      "trial_count": 15,
      "pub_count": 71
    },
    {
      "drug": "pembrolizumab",
      "disease": "ulcerative colitis",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "Checkpoint inhibitors CAUSE immune-related colitis",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 1,
      "pub_count": 9
    },
    {
      "drug": "quetiapine",
      "disease": "parkinson disease",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "Antipsychotics cause drug-induced parkinsonism via D2 blockade",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 4,
      "pub_count": 49
    },
    {
      "drug": "amiloride",
      "disease": "type 2 diabetes mellitus",
      "type": "cardiac_metabolic",
      "confidence": 0.5,
      "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
      "evidence": "HF and T2D frequently co-occur, creating false association",
      "trial_count": 1,
      "pub_count": 12
    },
    {
      "drug": "pantoprazole",
      "disease": "hypertension",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "PPIs associated with 17% increased hypertension risk",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 1,
      "pub_count": 33
    },
    {
      "drug": "quetiapine",
      "disease": "type 2 diabetes mellitus",
      "type": "inverse_indication",
      "confidence": 0.9,
      "reason": "Atypical antipsychotics CAUSE metabolic syndrome and T2D",
      "evidence": "Drug is known to CAUSE or WORSEN this condition",
      "trial_count": 1,
      "pub_count": 22
    },
    {
      "drug": "gentamicin",
      "disease": "type 2 diabetes mellitus",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "Aminoglycosides inhibit insulin release from beta cells",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 0,
      "pub_count": 13
    },
    {
      "drug": "imipramine",
      "disease": "hypertension",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 0,
      "pub_count": 55
    },
    {
      "drug": "protriptyline",
      "disease": "hypertension",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 0,
      "pub_count": 12
    },
    {
      "drug": "amitriptyline",
      "disease": "hypertension",
      "type": "mechanism_mismatch",
      "confidence": 0.85,
      "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
      "evidence": "Drug mechanism worsens disease pathophysiology",
      "trial_count": 0,
      "pub_count": 53
    },
    {
      "drug": "dobutamine",
      "disease": "type 2 diabetes mellitus",
      "type": "cardiac_metabolic",
      "confidence": 0.5,
      "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
      "evidence": "HF and T2D frequently co-occur, creating false association",
      "trial_count": 0,
      "pub_count": 22
    }
  ],
  "by_type": {
    "none": [],
    "cardiac_metabolic": [
      {
        "drug": "felodipine",
        "disease": "type 2 diabetes mellitus",
        "type": "cardiac_metabolic",
        "confidence": 0.5,
        "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
        "evidence": "HF and T2D frequently co-occur, creating false association",
        "trial_count": 0,
        "pub_count": 2
      },
      {
        "drug": "amiloride",
        "disease": "type 2 diabetes mellitus",
        "type": "cardiac_metabolic",
        "confidence": 0.5,
        "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
        "evidence": "HF and T2D frequently co-occur, creating false association",
        "trial_count": 1,
        "pub_count": 12
      },
      {
        "drug": "dobutamine",
        "disease": "type 2 diabetes mellitus",
        "type": "cardiac_metabolic",
        "confidence": 0.5,
        "reason": "Cardiac drug predicted for metabolic disease - comorbidity confounding possible",
        "evidence": "HF and T2D frequently co-occur, creating false association",
        "trial_count": 0,
        "pub_count": 22
      }
    ],
    "inverse_indication": [
      {
        "drug": "simvastatin",
        "disease": "type 2 diabetes",
        "type": "inverse_indication",
        "confidence": 0.9,
        "reason": "Statins INCREASE T2D risk (HR 1.12-1.44) but prescribed for CV protection",
        "evidence": "Drug is known to CAUSE or WORSEN this condition",
        "trial_count": 33,
        "pub_count": 345
      },
      {
        "drug": "hydrochlorothiazide",
        "disease": "type 2 diabetes mellitus",
        "type": "inverse_indication",
        "confidence": 0.9,
        "reason": "Thiazides cause hyperglycemia but prescribed for hypertension",
        "evidence": "Drug is known to CAUSE or WORSEN this condition",
        "trial_count": 15,
        "pub_count": 71
      },
      {
        "drug": "quetiapine",
        "disease": "type 2 diabetes mellitus",
        "type": "inverse_indication",
        "confidence": 0.9,
        "reason": "Atypical antipsychotics CAUSE metabolic syndrome and T2D",
        "evidence": "Drug is known to CAUSE or WORSEN this condition",
        "trial_count": 1,
        "pub_count": 22
      }
    ],
    "polypharmacy": [],
    "comorbidity": [],
    "mechanism_mismatch": [
      {
        "drug": "digitoxin",
        "disease": "type 2 diabetes",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "Na+/K+-ATPase inhibition reduces GLUT4 translocation, worsening glucose",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 0,
        "pub_count": 1
      },
      {
        "drug": "digoxin",
        "disease": "type 2 diabetes",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "Na+/K+-ATPase inhibition reduces GLUT4 translocation, worsening glucose",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 8,
        "pub_count": 45
      },
      {
        "drug": "pembrolizumab",
        "disease": "ulcerative colitis",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "Checkpoint inhibitors CAUSE immune-related colitis",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 1,
        "pub_count": 9
      },
      {
        "drug": "quetiapine",
        "disease": "parkinson disease",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "Antipsychotics cause drug-induced parkinsonism via D2 blockade",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 4,
        "pub_count": 49
      },
      {
        "drug": "pantoprazole",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "PPIs associated with 17% increased hypertension risk",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 1,
        "pub_count": 33
      },
      {
        "drug": "gentamicin",
        "disease": "type 2 diabetes mellitus",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "Aminoglycosides inhibit insulin release from beta cells",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 0,
        "pub_count": 13
      },
      {
        "drug": "imipramine",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 0,
        "pub_count": 55
      },
      {
        "drug": "protriptyline",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 0,
        "pub_count": 12
      },
      {
        "drug": "amitriptyline",
        "disease": "hypertension",
        "type": "mechanism_mismatch",
        "confidence": 0.85,
        "reason": "TCAs cause hypertension via norepinephrine reuptake inhibition",
        "evidence": "Drug mechanism worsens disease pathophysiology",
        "trial_count": 0,
        "pub_count": 53
      }
    ],
    "wrong_pathway": [],
    "cancer_target": []
  },
  "summary": {
    "total_scanned": 1052,
    "total_confounded": 15,
    "confounded_pct": 1.4258555133079849,
    "by_type_counts": {
      "none": 0,
      "cardiac_metabolic": 3,
      "inverse_indication": 3,
      "polypharmacy": 0,
      "comorbidity": 0,
      "mechanism_mismatch": 9,
      "wrong_pathway": 0,
      "cancer_target": 0
    }
  }
}